(Q46425301)

22 December 2017

title

Multiple effects of HMG-CoA reductase inhibitors (statins) besides their lipid-lowering function (English)

1 reference

22 December 2017

author name string

Bettina Haslinger-Löffler

series ordinal

1

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 September 2008

1 reference

22 December 2017

published in

Kidney International

1 reference

22 December 2017

volume

74

1 reference

22 December 2017

issue

5

1 reference

22 December 2017

page(s)

553-555

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1038/ki.2008.323

exact match

0 references

cites work

Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.323

7 January 2021

Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.323

7 January 2021

Pravastatin improves renal ischemia-reperfusion injury by inhibiting the mevalonate pathway.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.323

7 January 2021

Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.323

7 January 2021

Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.323

7 January 2021

Unexpected antimicrobial effect of statins

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.323

7 January 2021

Simvastatin increases fibrinolytic activity in human peritoneal mesothelial cells independent of cholesterol lowering

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.323

7 January 2021

Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-alpha-activated human peritoneal mesothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.323

7 January 2021

Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.323

7 January 2021

Identifiers

DOI

10.1038/KI.2008.323

1 reference

22 December 2017

release_uit5eqikavcwvizqul4tpt2azi

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uit5eqikavcwvizqul4tpt2azi

24 November 2022

mapped directly with Wikidata item

PubMed ID

18709024

1 reference

22 December 2017